Promising pre-clinical validation of targeted radionuclide therapy using a [131I] labelled iodoquinoxaline derivative for an effective melanoma treatment

M Bonnet-Duquennoy, J Papon, F Mishellany… - 2009 - dro.deakin.edu.au
Targeted internal radionuclide therapy (TRT) would be an effective alternative to current
therapies for dissemi-nated melanoma treatment. At our institution, a class of …
被引用次数：14 相关文章
[PDF] deakin.edu.au

[PDF][PDF] Promising Pre-clinical Validation of Targeted Radionuclide Therapy Using a [131I] Labelled Iodoquinoxaline Derivative for an Effective Melanoma Treatment

M Bonnet-Duquennoy, J Papon, F Mishellany… - J CancHU Sci …, 2009 - dro.deakin.edu.au
Targeted internal radionuclide therapy (TRT) would be an effective alternative to current
therapies for disseminated melanoma treatment. At our institution, a class of …
[PDF] archive.org

[PDF][PDF] Promising Pre-clinical Validation of Targeted Radionuclide Therapy Using a [131I] Labelled Iodoquinoxaline Derivative for an Effective Melanoma Treatment

M Bonnet-Duquennoy, J Papon, F Mishellany… - J CancHU Sci …, 2009 - scholar.archive.org
Targeted internal radionuclide therapy (TRT) would be an effective alternative to current
therapies for disseminated melanoma treatment. At our institution, a class of …
[PDF] academia.edu

[PDF][PDF] Promising Pre-clinical Validation of Targeted Radionuclide Therapy Using a [131I] Labelled Iodoquinoxaline Derivative for an Effective Melanoma Treatment

M Bonnet-Duquennoy, J Papon, F Mishellany… - J CancHU Sci …, 2009 - academia.edu
Targeted internal radionuclide therapy (TRT) would be an effective alternative to current
therapies for disseminated melanoma treatment. At our institution, a class of …